Clinical Trial Update: Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for liposomal irinotecan plus bevacizumab in irinotecan-refractory metastatic colorectal cancer. The study is Phase 1/Phase 2 and is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING